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Key statistics from the 2016 Cost Trends Report 
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Statutory mandate for HPC’s annual Cost Trends Report 
The commission shall compile an annual report concerning spending trends and underlying factors, along 
with any recommendations for strategies to increase the efficiency of the health care system. The report 
shall be based on the commission’s analysis of information provided at the hearings by providers, provider 
organizations and insurers, registration data collected under section 11, data collected by the Center for Health 
Information and Analysis under sections 8, 9 and 10 of chapter 12C and any other information the 
commission considers necessary to fulfill its duties under this section, as further defined in regulations 
promulgated by the commission. The report shall be submitted to the chairs of the house and senate committees 
on ways and means and the chairs of the joint committee on health care financing and shall be published and 
available to the public not later than December 31 of each year. The report shall include any legislative language 
necessary to implement the recommendations. 
▪ Hearings 
▪ Registration data 
▪ CHIA data 
▪ Any other information necessary to 
fulfill duties 
 
Data inputs 
Section 8g of Chapter 224 of the Acts of 2012 
▪ Annual report concerning spending 
trends and underlying factors 
▪ Recommendations for strategies to 
increase efficiency 
▪ Legislative language necessary to 
implement recommendations 
 
Required outputs 
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Presentation themes and potential areas for recommendations 
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Massachusetts healthcare spending growth 
 
 After years of high growth in annual healthcare spending throughout the 2000s, 
Massachusetts spent more than any other state on health care per person in 2009 
 Medicare spending per capita was 9% higher 
 Commercial premiums were 13% higher 
 
 Since 2012, the state (through the HPC) annually establishes a health care cost 
growth benchmark, as measured by growth in total health care expenditures 
(THCE) per capita. This target is based on projections of the state’s long-term 
economic growth and has been set at 3.6% annual growth through 2017 
 
 Since 2012, the actual growth rates in THCE were: 
 2012-2013: 2.4% 
 2013-2014: 4.2% 
 2014-2015 preliminary: 4.1% 
 
 Overall, between 2012-2015, the average growth rate in TCHE was 3.57% 
 
 
 
 
Background 
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Growth in prescription drug spending, among other factors, contributed to 
exceeding the benchmark in 2015 
Note: Prescription drug figures under MassHealth include MCO, PCC and FFS spending only and exclude PACE, SCO and One Care. Prescription drug figures exclude 
impact of rebates. Growth figures provided are per member or per enrollee (Medicare drug spending is per Part D enrollee) 
Sources: HPC analysis of Center for Health Information and Analysis 2016 Annual Report and July 2016 Enrollment Trends Report 
Sector/spending 
category 
Drivers of growth beyond benchmark rate, 
2014-2015 
Commercial  • Prescription drugs (8.9% growth, not factoring 
rebates) 
Medicare (FFS) • Prescription drugs (10.9% growth, not factoring 
rebates) 
• Home health care (6.6% growth) 
MassHealth  • Prescription drugs (9.1% growth, not factoring 
rebates) 
• Long term services and supports (LTSS), 
particularly spending on home and community-
based services 
Other • Medicare enrollment growth (Original Medicare, 
One Care and Senior Care Options) 
• Net cost of private health insurance 
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Note: U.S. data includes Massachusetts. 
Sources: Centers for Medicare and Medicaid Services National Healthcare Expenditure Accounts, Personal Health Care Expenditures Data, and State Healthcare 
Expenditure Accounts (U.S. 2002-2015 and MA 2002-2009); Center for Health Information and Analysis Annual Report THCE Databook (MA 2009-2015) 
Since 2009, total healthcare spending growth in Massachusetts has been 
near or below national growth 
Annual growth in per capita healthcare spending, MA and the U.S., 2002-2015 
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In recent years, commercial spending growth in Massachusetts has been 
consistently lower than national growth 
Annual growth in commercial health insurance premium spending from previous year, per enrollee 
Notes: U.S. data includes Massachusetts. Center for Health Information and Analysis data are for the fully-insured market only. 
Sources: Centers for Medicare and Medicaid Services, State and National Healthcare Expenditure Accounts, Private Health Insurance Expenditures and Enrollment 
(U.S. and MA 2005-2009); Center for Health Information and Analysis Annual Reports (MA 2009-2015) 
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Despite recent lower growth, spending per person in Massachusetts 
remains 6-7% higher than U.S. averages  
Commercial  
 Milliman, Inc. (claims-based), 2014 
 6% overall (statewide) 
 9% Boston-area 
 U.S. Agency for Healthcare Research and Quality (survey of employers), 2015 
 6.5% family premiums 
 9.3% single premiums 
Sources: Centers for Medicare and Medicaid Services 2016 (Medicare); Milliman, Inc., 2014 and Agency for Healthcare Research and Quality Medical 
Expenditure Panel Survey, 2015 (commercial) 
Massachusetts per person spending in excess of U.S. averages, 2014 and 2015 
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Massachusetts has a considerable portion of residents at low to middle 
income levels 
Number of state residents at each household income level, 2015 
Note: Dollar values are for a family of two adults and one child. 
Source: Current Population Survey as reported by Kaiser Family Foundation  
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On average, health insurance premiums in Massachusetts are relatively 
similar for low- and high-wage employers, but the employee share is 
greater among lower-wage employers 
Average family premiums and employee contributions, by wage quartile, 2015 
Source: Agency for Healthcare Research and Quality Medical Expenditure Panel Survey, 2015; Executive Office of Labor and Workforce Development 2015 
Massachusetts Workforce and Labor Area Review 
Average premium plus typical cost sharing was $20,400 in 2015 while the 
average wage was $64,116 
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Out-of-pocket healthcare spending is relatively similar for residents in 
low and high income areas 
Percent of residents, by annual out-of-pocket spending, 2014 
Notes: Spending includes only out-of-pocket spending within insurance benefits (e.g. copays and deductibles) and is conditional on having non-zero spending. Lowest 
income areas represent the quartile of zip codes in the state with the lowest household median income. Data include only privately insured individuals covered by Tufts 
Health Plan, Blue Cross Blue Shield of MA, and Harvard Pilgrim Health Care. Data do not include spending outside of health insurance such as dental care, over-the-
counter medications, or privately-paid mental health visits. 
Source: HPC analysis of Massachusetts All-Payer Claims Database, 2014 
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Massachusetts residents with low to middle incomes face a high burden 
of healthcare costs relative to income 
Total healthcare spending relative to income for a family with employer-based coverage, 2015 
Note: FPL= federal poverty level. Calculation assigns premium (including employer and employee contribution) for lowest-wage quartile employers (from private health 
insurance premium slide) to the 200% FPL family, the second highest-quartile to the 400% FPL family and the highest-quartile premium to the 600% FPL family. Cost 
sharing is assigned as a fixed proportion of the total premium using total cost sharing as reported by the Center for Health Information and Analysis. Calculations do 
not account for tax deductibility of employer-sponsored health insurance premiums or spending on health care outside of covered benefits.  
Source: HPC analysis of Agency for Healthcare Research and Quality Medical Expenditure Panel Survey, 2015 
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Out-of-network charges can also burden patients and impact spending 
Proportion of ED visits at in-network facilities that involved out-of-network physicians 
 A 2016 study published in the New England Journal of Medicine showed that of ED visits at in-
network hospitals, 22% involved out-of-network physicians 
 Eastern MA was above the national average while the Worcester area was below 
 Out-of-network emergency physicians charged an average of 798% of Medicare rates 
 These costs are borne by both patients and insurers 
 Massachusetts policy makers are exploring the topic of out-of-network billing 
Notes: ED= emergency department. A recent MassHealth policy change caps Managed Care Organization (MCO) reimbursements for out-of-network non-emergency 
services at 100% of MassHealth fee-for-service rates. The Special Commission on Provider Price Variation is considering out-of-network billing issues in the scope of its 
ongoing work, which could result in policy action.  
Source: Zack Cooper & Fiona Scott Morton, Out-of-Network Emergency-Physician Bills – An Unwelcome Surprise, New England Journal of Medicine 375, 1915-18 (2016) 
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 For the second year in a row, prescription drug spending in Massachusetts exceeded 
historical growth rates (10.2% in 2015 and 13.5% in 2014) 
 This growth is consistent with national trends 
 The entry of new high-cost drugs, price growth for existing drugs, and a low level of 
patent expirations remained the largest contributors to drug spending growth in 2015 
 
 Commercial prescription drug spending grew 8.8% per capita in 2015, down from 12.5% in 
2014 
 
 The estimates above do not factor rebates, which affect both level and trend 
 AGO reports that commercial* per capita prescription drug spending growth in 2015 
was two percentage points lower net of rebates: from 8.2% to 6.1% 
 
 Even including rebates, growth in prescription drug spending exceeded spending growth 
in all other commercial categories of service 
Prescription drug spending 
Background 
 
*Note: Analysis only includes five Massachusetts health plans. 
Source: Office of the Attorney General. Examination of Health Care Cost Trends and Cost Drivers Pursuant to G.L. c. 12C, § 17. Boston (MA) : Office of the 
Attorney General; 2016 October 7 
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Among major spending categories, prescription drugs have the highest 
growth rate 
Growth in commercial spending categories and proportion of total TME, 2013-2015 
Note: TME= total medical expenses. Prescription drug figures exclude impact of rebates. 
Source: HPC analysis of Center for Health Information and Analysis 2016 Annual Report TME Databook 
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Note: 2015 medical drug spending data is estimated based on 2013 and 2014 share of spending. Figures exclude impact of rebates.  
Source: HPC analysis of Massachusetts All-Payer Claims Database, 2012-2014 (medical drug spending) and Center for Health Information and Analysis Annual Report 
TME Databooks (prescription drug spending) 
Medical and prescription drug spending combined comprise over 20% of 
commercial health spending in Massachusetts 
Percent of commercial healthcare spending, by drug benefit type, 2013-2015 
 Medical drugs are administered by providers (e.g. chemotherapeutic agents, flu vaccine) 
 Medical drug spending grew 4% per capita from 2013 to 2014, with ~ 6% annual per 
capita growth from 2011 to 2014 
 Combined medical and prescription drug spending represents a growing share of total 
health spending  
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Notes: PMPY= per member per year. Data include only privately insured individuals covered by Tufts Health Plan, Blue Cross Blue Shield of MA, and Harvard 
Pilgrim Health Care who use the prescription drug benefit at least once in the calendar year. Figures exclude impact of rebates.  
Source: HPC analysis of Massachusetts All-Payer Claims Database, 2012-2014 
From 2012-2014, total drug spending increased while average cost 
sharing declined 
Average spending and cost sharing for generic and branded drugs, per member per year, 2012-2014 
During this time period, the Affordable Care Act (ACA) prohibited payers from 
imposing patient cost sharing – copayments or coinsurance – on many preventative 
drugs 
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Notes: Data include only privately insured individuals covered by Tufts Health Plan, Blue Cross Blue Shield of MA, and Harvard Pilgrim Health Care. Includes 
only commercial users of the pharmacy drug benefit. Figures exclude impact of rebates.  
Source: HPC analysis of Massachusetts All-Payer Claims Database, 2012-2014 
From 2012-2014, the proportion of drugs with no cost sharing increased 
Percent of claims, by cost sharing amount, 2012-2014 
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Notes: PMPY= per member per year. Data include privately insured individuals covered by Tufts Health Plan, Blue Cross Blue Shield of MA, and Harvard 
Pilgrim Health Care who use the prescription drug benefit at least once in the calendar year. Figures exclude impact of rebates.  
Source: HPC analysis of Massachusetts All-Payer Claims Database, 2012-2014 
From 2012-2014, cost sharing on prescription drugs decreased 
substantially for women, due in large part due to the ACA 
 Many contraceptive methods are included under the ACA’s 
mandatory coverage  
 Average annual cost sharing particularly dropped for women 
from 2012 to 2014 – a 14% decline ($205 to $176) versus a 
4% decline for men ($202 to $193) 
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Notes: Data include only privately insured individuals covered by Tufts Health Plan, Blue Cross Blue Shield of MA, and Harvard Pilgrim Health Care who use 
the prescription drug benefit at least once in the calendar year. Figures exclude impact of rebates.  
Source: HPC analysis of Massachusetts All-Payer Claims Database, 2012-2014 
From 2012-2014, EpiPen prices increased rapidly, though generally without 
an impact on cost sharing 
Average spending and cost sharing on Mylan’s EpiPen, per claim, 2012-2014 
However, in 2014 a small portion of the Massachusetts commercial population paid most or all of 
EpiPen’s cost out-of-pocket –  2.9% paid more than $100 and 1.3% paid more than $300   
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Hospital use and post-acute care (PAC) 
 Hospital and PAC use in Massachusetts continues be higher than the nation 
overall 
 
 Compared to the U.S. average, in 2015 Medicare spent 19% more on inpatient 
hospital services, 24% more on outpatient hospital services, and 18% more on 
PAC* for Massachusetts enrollees 
 
 The HPC has previously identified opportunities to improve quality and enhance 
efficiency in this category (e.g. reducing readmissions, avoidable ED visits) 
Background 
*Note: Includes home health and skilled nursing facilities. 
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Hospital use in Massachusetts remains higher than national averages 
Note: ED= emergency department. 
Source: Kaiser Family Foundation analysis of American Hospital Association data, 2010-2014 
Hospital use in MA and U.S., per 1,000 population, 2010-2014 
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While ED visits have declined overall, behavioral health-related visits 
have increased steadily 
ED visits by category, per 1,000 population, 2011-2015 
 
Notes: ED= emergency department; BH= behavioral health. The total ED rate (in orange above the bars) includes all categories of ED visits, including unclassed ED 
visits which are not shown here. Unclassified visits increased 5.7% during this time period. Definition of ED categories based on NYU Billings Algorithm categorization of 
a patient’s primary diagnosis and are mutually exclusive. BH ED visits includes any discharge with a primary mental health, substance use disorder, or alcohol-related 
diagnosis code. Emergency visits include the Billings categories of  emergency and emergent, ED care preventable; avoidable visits include the Billings categories of 
non-emergent and emergent, primary care treatable. Some non-Massachusetts residents are included in the number of ED visits. In 2015, 4% of all ED visits in 
Massachusetts were made by non-Massachusetts residents. 
Source: HPC analysis of Center for Health Information and Analysis Emergency Department Database, 2011-2015 
The growth in BH-related ED visits was in part due to increases in opioid-related ED visits, which 
grew 87% from 2011 to 2015 
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Behavioral health patients are increasingly more likely to have an extended 
length of stay in the ED 
Percent of ED visits with a length of stay of more than 12 hours, by primary diagnosis type, 2011-2015 
Notes: ED= emergency department; BH=behavioral health. BH ED visits identified using  NYU Billings algorithm and include any discharge with a primary 
mental health, substance abuse, or alcohol-related diagnosis code. Length of stay is calculated as the difference between the point of registration and the 
point of admission or discharge. 
Source: HPC analysis of Center for Health Information and Analysis Emergency Department Database, 2011-2015 
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After three years of annual declines of over 20,000, inpatient admissions 
increased in 2015, driven by patients 65 and over 
Inpatient admissions per 1,000 population, by age category, 2011-2015 
Notes: Some non-Massachusetts residents are captured in the Massachusetts admissions. In 2015, non-Massachusetts residents represented 5% of all 
inpatient admissions. 
Source: HPC analysis of Center for Health Information and Analysis Hospital Inpatient Discharge Database, 2011-2015 
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Massachusetts hospital readmissions began increasing in 2014 after a 
sustained decline 
Sources: Centers for Medicare and Medicaid Services (U.S. Medicare and MA Medicare 2011-2013); Center for Health Information and Analysis (all-payer and MA 
Medicare 2014-2015) 
Thirty-day readmission rate, by payer, MA and the U.S., 2011-2014 
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Inpatient care that could safely and effectively be provided in community 
hospitals is increasingly being provided by teaching hospitals 
Notes: Discharges that could be appropriately treated in community hospitals were determined based on expert clinician assessment of the acuity of care provided, as 
reflected by the cases’ diagnosis-related groups (DRGs). The Center for Health Information and Analysis (CHIA) defines community hospitals as general acute care 
hospitals that do not support large teaching and research programs. Teaching hospitals are defined as hospitals that report at least 25 full-time equivalent medical 
school residents per one hundred inpatient beds in accordance with Medicare Payment Advisory Commission (MedPAC) guidelines. Academic medical centers are a 
subset of teaching hospitals characterized by (1) extensive research and teaching programs, (2) extensive resources for tertiary and quaternary care, (3) principal 
teaching hospitals for their respective medical schools, and (4) full service hospitals with case mix intensity greater than 5 percent above the statewide average.  
Source: HPC analysis of Center for Health Information and Analysis Hospital Inpatient Discharge Database, 2011-2015 
Share of community appropriate discharges, by hospital type, 2011-2015 
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However, following Lahey’s acquisition of Winchester (a community 
hospital) in 2014, community appropriate discharges increased at 
Winchester and decreased at Lahey Medical Center (a teaching hospital) 
Notes: Discharges that could be appropriately treated in community hospitals were determined based on expert clinician assessment of the acuity of care provided, 
as reflected by the cases’ diagnosis-related groups (DRGs). All other discharges are classified as “higher acuity” for the purposes of this analysis.  
Source: HPC analysis of Center for Health Information and Analysis Hospital Inpatient Discharge Database, 2012-2015 
Discharges at Lahey and Winchester hospitals, by type, 2012-2015 
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Massachusetts has a higher rate of discharge to institutional PAC than the 
U.S. average 
Discharge destination following an inpatient admission, by payer, 2013 
 
Notes: PAC=post-acute care. Institutional includes skilled nursing facilities, short-term hospitals, intermediate care facilities (ICF), and another type of facility.  
Sources: HPC analysis of Healthcare Cost and Utilization Project (HCUP) Massachusetts State Inpatient Database & Nationwide Inpatient Sample Survey, 
2013 
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Since 2010, home health PAC use is increasing, while institutional PAC use 
remains fairly constant 
Notes: PAC= post-acute care. Data include adult patients who were discharged to routine care or some form of PAC. Discharges from hospitals that closed and specialty 
hospitals, except New England Baptist, were excluded. Discharges from UMass Memorial, Cape Cod, Marlborough, Clinton and Falmouth hospitals were excluded due to 
coding irregularities in the database. Institutional PAC settings include skilled nursing facilities, inpatient rehabilitation facilities, and long-term care hospitals. Adjusted using 
ordinary least squares (OLS) regression to control for changes in mix of diagnosis-related groups (DRGs) over time.  
Source: HPC analysis of Center for Health Information and Analysis Hospital Inpatient Discharge Database, 2010-2015 
 
Discharge destination following an inpatient admission, adjusted for DRG mix, 2010-2015 
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Medicare beneficiaries in Massachusetts spend more time in hospitals 
and skilled nursing facilities (SNFs) than in most regions of the country 
Notes: SNF= skilled nursing facility. Inpatient days= SNF days + hospital inpatient days.  
Source: Dartmouth Atlas, 2012 
Combined inpatient hospital and SNF days, per Medicare beneficiary, 2012 
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Variation in spending by primary care provider (PCP) group 
 Massachusetts has higher commercial spending per enrollee compared to the U.S. 
average, particularly on physician services and outpatient care1 
 HPC assessed two measures of spending by primary care provider (PCP) group: total 
medical expenses (TME) and non-recommended care  
 
Total medical expenses 
 TME includes all medical care spending for patients with an assigned PCP for 
enrollees in HMO and POS products 
 Comparing TME across provider groups allows for comparison of resources used to 
care for comparable (health status adjusted) patients and reflects differences in both 
practice patterns and prices 
 Comparisons can help inform supply-side (e.g. APMs) and demand-side (e.g. premium 
differentials by PCP group) incentives that are based on TME 
Background 
Notes: Includes TME only for members of Blue Cross Blue Shield of MA, Tufts Health Plan and Harvard Pilgrim Health Care. HMO= health maintenance organization, 
POS= point of service, APM= alternative payment methods 
Source: 1Milliman, Inc., 2014 
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Notes: TME= total medical expenses, Blended TME is the combined normalized health status adjusted TME weighted across the three largest commercial payers (see 
Technical Appendix for details). Analysis includes the 10 largest primary care groups as identified by the Center for Health Information and Analysis (CHIA) in terms of 
member-months: Partners Community Physicians Organization (Partners); New England Quality Care Alliance (NEQCA), a corporate affiliate of Wellforce; Beth Israel 
Deaconess Care Organization (BIDCO); Steward Health Care Network (Steward); Atrius Health (Atrius); Lahey Clinical Performance Network (Lahey); Mount Auburn 
Cambridge IPA (MACIPA); UMass Memorial Medical Group (UMass Memorial); Boston Medical Center Management Services (BMC); and Baycare Health Partners 
(Baycare).   
Source: HPC analysis of Center for Health Information and Analysis  2016 Annual Report TME Databook 
TME by PCP group has converged somewhat over time, with the 
exception of Partners 
Blended health status adjusted TME, per member per month, 2012-2015  
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Notes: Blended TME is the combined normalized health status adjusted TME weighted across the three largest commercial payers (see Technical Appendix for details). 
Analysis includes the 10 largest primary care groups: Partners Community Physicians Organization (Partners); New England Quality Care Alliance (NEQCA), a corporate 
affiliate of Wellforce; Beth Israel Deaconess Care Organization (BIDCO); Steward Health Care Network (Steward); Atrius Health (Atrius); Lahey Clinical Performance Network 
(Lahey); Mount Auburn Cambridge IPA (MACIPA); UMass Memorial Medical Group (UMass Memorial); Boston Medical Center Management Services (BMC); and Baycare 
Health Partners (Baycare).  
Source: HPC analysis of Center for Health Information and Analysis  2016 Annual Report TME Databook  
Reported patient acuity has increased 3% per year; as a result, unadjusted 
TME growth is substantially higher than health status adjusted TME growth 
Growth in blended TME, 2012-2015 
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High APM uptake has been followed by lower TME growth in the next year 
Notes: APM= alternative payment methods. High APM uptake defined as providers with more than 74 percent of their members under APMs. Blended TME is the combined 
normalized health status adjusted TME weighted across the three largest commercial payers (see Technical Appendix for details). Analysis includes the 10 largest primary 
care groups: Partners Community Physicians Organization (Partners); New England Quality Care Alliance (NEQCA), a corporate affiliate of Wellforce; Beth Israel Deaconess 
Care Organization (BIDCO); Steward Health Care Network (Steward); Atrius Health (Atrius); Lahey Clinical Performance Network (Lahey); Mount Auburn Cambridge IPA 
(MACIPA); UMass Memorial Medical Group (UMass Memorial); Boston Medical Center Management Services (BMC); and Baycare Health Partners (Baycare). 
Source: HPC analysis of Center for Health Information and Analysis 2016 Annual Report APM and TME Databooks 
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Examining non-recommended care as an opportunity for improvement 
 
 
 
 
 
 
 This analysis was informed by the Choosing Wisely campaign, in which physician 
specialty groups defined wasteful or unnecessary screenings, procedures, and tests 
within their own specialty. Non-recommended care is alternatively referred to as “low-
value care” 
 
 Previous work has examined practice pattern variation by region and payer, while 
HPC’s analysis also examines measures of utilization by primary care provider group 
 Through combination of the Massachusetts All-Payer Claims Database with the 
Registry of Provider Organizations dataset 
 
 Methods to measure non-recommended care are based on previous studies care: 
 Rosenthal et. Al, “Choosing Wisely:  prevalence and correlates of low-value 
health care services in the United States”, Journal of General Internal Medicine 
(2015) 
 Schwartz et. Al, “Measuring low-value care in Medicare”, Journal of American 
Medical Association (2016) 
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Measures of non-recommended care analyzed by HPC  
Source: HPC analysis of Massachusetts All-Payer Claims Database, 2013 and 2014 
Measures and number of instances in MA, 2013-2014 
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Some provider groups had consistently low or high rates of non-
recommended care across measures 
Rates of non-recommended care, by provider group relative to the statewide average (indexed to 1.0 
for each measure), 2013 
Notes: Analysis includes the same provider groups in the Total Medical Expenses (TME) analysis with the exception of NEQCA. Some measures are not reported for 
some organizations due to cell size limitations. Data include only privately insured individuals covered by Tufts Health Plan, Blue Cross Blue Shield of MA, and Harvard 
Pilgrim Health Care.  
Source: HPC analysis of Massachusetts All-Payer Claims Database, 2013 and Registry of Provider Organizations, 2016 
statewide average 
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Rates of non-recommended imaging vary by region 
Back imaging for non-specific back pain 
(n=89,788) 
Imaging for diagnosis of plantar fasciitis 
(n=19,976) 
Notes: Data include only privately insured individuals covered by Tufts Health Plan, Blue Cross Blue Shield of MA, and Harvard Pilgrim Health Care.  
Source: HPC analysis of Massachusetts All-Payer Claims Database, 2013 and 2014 
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Alternative payment methods (APMs) 
 APMs align financial incentives with care delivery goals 
 
 In 2015, HPC set targets for APM adoption in the Commonwealth: 
 
 APMs for HMO patients: All commercial payers should increase the use of APMs, 
with the goal of having 80% of the state HMO population in APMs by 2017 
 APMs for PPO patients: Commercial payers should seek to increase the use of 
APMs for members enrolled in PPO plans, with the initial goal of having one-
third of the state PPO population in APMs by 2017 
Background 
Notes: HMO= health maintenance organization, PPO= preferred provider organization. 
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Notes: * denotes that 2015 results based on preliminary estimates. Original Medicare= fee-for-service, APM= alternative payment method, CY= calendar year, PPO= 
preferred provider organization, MACRA= Medicare Access and CHIA Reauthorization Act of 2015, ACO= accountable care organization.  
Sources: Centers for Medicare and Medicaid Services, 2013-2015; Center for Health Information and Analysis 2016 Annual Report APM Databook 
While progress on APMs stalled in 2015, there are several promising 
developments for 2016 and beyond 
Proportion of member months under APMs, by insurance category, CY 2013-2015 
 Commercial: Developments in expanding APMs into PPO products, including one major commercial 
payer which is extending its APM to PPO members served by several large providers systems  
 Medicare: Implementation of MACRA to link quality to physician payments, adoption of the Next 
Generation ACO program, and introduction of new bundled payment initiatives 
 MassHealth: Implementation of MassHealth ACO program, as supported the Delivery System 
Reform Incentive Program (DSRIP) and the amended 1115 waiver 
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Demand-side incentives (DSI) 
 DSIs reduce healthcare spending and improve market functioning by encouraging 
individuals and employers to make value-based choices, including: 
 Tiered and limited network plans  
 Cash-back incentives and price transparency programs 
 Reference pricing products 
 
 These mechanisms are enabled and fostered by: 
 Informed and activated employers and employees 
 Price and quality transparency 
 Competitive insurance markets such as exchanges 
 
 
 
Background 
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Some incremental progress on DSI 
 Mechanisms include: 
 Cash-back incentives  
 Unicare adds cash-back option for GIC members (2016) 
 Tiered and limited network products 
 Limited network products increased from 3.0% to 3.2% of commercial 
market in 2015 while tiered networks decreased from 16.0% to 15.9% 
 
 Enabling forces include: 
 Price transparency 
 Several insurers, notably Blue Cross Blue Shield of MA and Harvard 
Pilgrim Health Care, reported increase in website hits from 2015 to 2016 
 The Center for Health Information and Analysis is planning to launch a 
statewide price and quality website in 2017 
 Market structure 
 The HPC has conducted an analysis on small and mid-size employers to 
understand if 1) their employees served well by the health insurance 
market, and 2) these employers able to enable and foster high-value 
insurance choices 
 
 
 
Source: ??? 
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Note: HDHP= high-deductible health plan. 
Source: HPC analysis of Center for Health Information and Analysis Massachusetts Employer Survey, 2014 
Most small group employees do not have a choice of plans 
Among employees offered coverage by their firms, percent with plan choice by company size, 2014 
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Notes: Graph on left defines small employers as those with fewer than 100 employees; graph on right defines small employers as those with fewer than 50 employees. In 
2015, the vast majority (75%) of employees at firms with fewer than 100 employees were in firms with fewer than 50 employees.  
Source: Kaiser Family Foundation analysis of  data from Mark Farrah Associates, 2010-2013  
Small group employers pay more in broker fees and other insurance 
administrative costs 
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Small and mid-size employers noted challenges in offering competitive 
insurance options 
Source: HPC and Associated Industries of Massachusetts (AIM)  survey of 188 Massachusetts employers, 2015 
Percent of firm representatives answering yes (multiple affirmative responses allowed), 2015 
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Notes: Top graph shows the average for the second-lowest silver plan premium for a 40 year old non-smoker earning $30,000 per year in the largest city in 
each state; bottom graph reflects the average monthly single premium for a private sector firm with fewer than 50 employees. 
Sources: Kaiser Family Foundation, 2016 (top); Agency for Healthcare Research and Quality, 2015 (bottom) 
Massachusetts Health Connector premiums are below the national 
average, but employer based small-group premiums are higher  
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2016 Cost Trends Report: summary of preliminary findings 
 Recent spending growth per person in Massachusetts continues to be below national rates; 
Massachusetts now spends about 6-7% more on health care than other states, down from about 
9-13% more in 2009 
 Overall, Massachusetts residents benefitted from lower prescription drug cost sharing from 2012-
2014, due in large part to protections in the Affordable Care Act  
 Early directional evidence suggests adoption of Alternative Payment Methods (APMs) may 
contribute to moderated spending growth for certain primary care provider groups 
 Premiums for individual coverage offered through the Massachusetts Health Connector are below 
the U.S. average, unlike employer-based coverage 
 
 
 Hospital utilization and readmissions increased in 2015 after years of decline 
 Community appropriate care is continuing to increase at teaching hospitals 
 While moderating somewhat in 2015, prescription drug spending in Massachusetts continues to 
grow more rapidly than any other category of service  
 Rates of behavioral health-related ED use and ED boarding are increasing 
 Post-acute care spending and utilization – particularly use of institutional care – remains high 
 Growth in APM coverage stalled in 2015, though there are promising signs for 2016 and beyond 
 Most small employers do not offer employees choice of insurance plan and pay higher 
broker/administrative fees  
 
Promising Developments 
Challenging Developments 
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Dashboard: Benchmark and spending 
Key 
area 
Measure MA time trend   
Comparison 
U.S.  Target 
B
e
n
c
h
m
a
rk
 a
n
d
 s
p
e
n
d
in
g
 
1. Growth of THCE per capita (performance 
assessed relative to 3.6% benchmark) 
4.2% 
(2013-2014) 
 4.1% 
(2014-2015)  
5.1% 
(2014-2015) 
< 3.6% 
2. Growth in commercial premiums 
1.4% 
(2013-2014) 
1.6% 
(2014-2015) 
5.2% 
(2014-2015) 
  
2a. Level of commercial premiums 
Family: $17,702 
Single: $6,348 
(2014) 
Family: $18,454 
Single: $6,519 
(2015) 
Family: $17,322 
Single: $5,963 
(2015) 
  
3. Individuals with high out-of-pocket spending 
relative to income 
11% 
(2013-2014) 
11%  
(2014-2015) 
14% 
(2014-2015) 
  
Similar performance Better performance Worse performance Projected performance 
 54 
Dashboard: Efficient, high-quality care delivery 
Key 
area 
Measure MA time trend   
Comparison 
U.S.  Target 
E
ff
ic
ie
n
t,
 h
ig
h
-q
u
a
li
ty
 c
a
re
 d
e
li
v
e
ry
 
4. Readmission rate (Medicare) 
17.7% 
(2014) 
18.2% 
(2015) 
  MA ranked  
43rd out of 51  
(U.S. = 16.8%) 
 (2014) 
  
4a. Readmission rate  
(All payer) 
15.3% 
(2014) 
15.8% 
(2015) 
N/A 
< 13% by 
2019 
5. ED utilization (per 1,000 persons) 
366 
(2014) 
364 
(2015) 
 MA ranked 
 32nd out of 51   
(2014) 
  
5a. BH-related ED utilization (per 1,000 
persons) 
25.6 
(2014) 
26.0 
(2015) 
MA = 25.4 
U.S. = 17.8    
(2013) 
  
6. Percentage of inpatient discharges to 
institutional PAC 
19.7% 
(2014) 
  19.4% 
(2015) 
 MA = 21.8%   
U.S. = 17.1% 
(2013) 
  
7. At-risk adults without a doctor visit 
7% 
(2014) 
7% 
(2015) 
13% 
(2015) 
  
8. Number of primary care physicians 
practicing in certified PCMHs 
2,024 
25.3% of all PCPs 
 (2015) 
2,347 
28.6% of all PCPs 
 (2016) 
16.3% of all PCPs 
(2016) 
33% by 2017; 
20% in Prime 
practice by 
2017 
9. Hospital inpatient days in last 6 months of 
life (Medicare 65+) 
N/A 
8.5 
(2012) 
8.7 
(2012) 
  
10. Of decedents who used hospice, percent 
who used hospice for 7 days or less 
N/A 
30.9% (2012)  
(Medicare 65+) 
35.5% (2012)  
(All decedents) 
  
Similar performance Better performance Worse performance Projected performance 
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Dashboard: Alternative payment methods (APMs) 
Key 
area 
Measure MA time trend   
Comparison 
U.S.  Target 
A
P
M
s
 
11. Percentage of beneficiaries in Original 
Medicare covered by APMs 
40% 
(2014) 
 38% 
(2015) 
20% 
(2015) 
  
12. Percentage of commercial HMO patients 
in APMs 
64% 
 (2014) 
 58% 
(2015) 
N/A 80% by 2017 
13. Percentage of commercial PPO patients in 
APMs 
2% 
(2014) 
1% 
(2015) 
N/A 33% by 2017 
14. Percentage of MassHealth members in 
APMs 
PCC: 22%  PCC: 23%  
N/A 
  
MCO: 31% MCO: 32%    
(2014) (2015)   
Similar performance Better performance Worse performance Projected performance 
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Dashboard: Value-based markets 
Key 
area 
Measure MA time trend   
Comparison 
U.S.  Target 
V
a
lu
e
-b
a
s
e
d
 m
a
rk
e
ts
 
15. Enrollment in tiered and limited network 
products  
 19.1%  
(2014) 
 19.1% 
(2015) 
N/A   
16. Percentage of discharges in top 5 systems 
 60.9% 
(2014) 
 59.9%  
(2015) 
N/A   
17. Percentage of community appropriate 
discharges from community hospitals 
  53.6% 
 (2014) 
  53.3%  
(2015) 
N/A   
Similar performance Better performance Worse performance Projected performance 
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Key statistics from the 2016 Cost Trends Report 
